This medical tool calculates a 2-year risk score for death and/or heart failure hospitalization in patients with specific heart conditions. It combines clinical and echocardiographic data to aid in shared decision-making regarding treatment options.





249+ iOS apps curated and reviewed
The best coapt risk score apps on iPhone average 4.4★ across 249+ titles — we've ranked them by what real users actually keep on their phones. Updated August 2026.
| # | App | Price | Rating | Ads | In-App Purchases | Updated |
|---|---|---|---|---|---|---|
| 1 | Free | 5.0★ (1) | No | No | May 2026 | |
| 2 | Free | 1.0★ (1) | No | No | May 2026 | |
| 3 | Free | 4.9★ (52K) | No | No | Aug 2026 | |
| 4 | Free | — | No | No | May 2026 | |
| 5 | Free | 5.0★ (8) | No | No | May 2026 | |
| 6 | Free | — | No | No | May 2026 | |
| 7 | Free | 5.0★ (1) | No | No | May 2026 | |
| 8 | Free | 4.9★ (1.2K) | No | No | Aug 2026 |





This medical tool calculates a 2-year risk score for death and/or heart failure hospitalization in patients with specific heart conditions. It combines clinical and echocardiographic data to aid in shared decision-making regarding treatment options.



This medical app helps physicians estimate survival probability for patients with chronic heart failure. It uses four key patient characteristics, including medication, symptoms, exercise capacity, and blood test results, to provide these estimates. The calculations are based on data from a specialized heart failure clinic.






This app provides over 900 evidence-based medical calculators, risk scores, and clinical tools for healthcare professionals. It offers offline functionality, expert insights, and CME tracking to support patient care at the bedside. Tools are developed and validated by board-certified physicians.




This app helps users of upper limb prostheses calibrate, set up, and practice controlling their devices. It offers real-time feedback, diagnostic tools, and AI-powered coaching to improve prosthesis control.




This medical app offers personalized referral and treatment guidance for mitral regurgitation patients. It analyzes echo assessment parameters to determine MR severity, etiology, and recommend appropriate interventions like valve repair or replacement.


Access comprehensive clinical guideline recommendations and utilize interactive tools like risk scores and calculators. This app provides a mobile resource for healthcare professionals managing cardiovascular disease patients, offering features such as bookmarks and note-taking.


This clinical decision support tool offers personalized heart failure therapy recommendations for healthcare professionals. It guides clinicians on medication initiation, titration, and optimization based on patient indications, referencing the latest guidelines.


This medical app provides a dedicated risk-score model to predict outcomes for patients undergoing isolated tricuspid valve surgery. It utilizes pre-operative clinical, biological, and echocardiographic data to guide clinical decision-making in routine practice.


This app provides healthcare professionals with calculators to assess individual cardiovascular risk for primary and secondary prevention. It offers multiple scoring systems to guide the selection of the most adapted calculator for patient risk estimation. Patient data is not stored within the application.


This clinical decision support app provides comprehensive cardiovascular disease risk assessments for clinicians. It unifies two major risk calculators, incorporating traditional ASCVD modeling with modern kidney and metabolic health measures for personalized patient care.








This tool assists cardiothoracic surgery teams in evaluating patient surgical risk. It utilizes current data from a national database to provide accurate risk assessments.


This application provides a risk scoring tool for cardiovascular disease, incorporating coronary artery calcium scores. It aims to help guide preventive therapies like diet, exercise, and medication based on individual risk factors. The results are intended to inform, not replace, clinical judgment.


This tool helps clinicians assess the risk and benefit of continuing dual antiplatelet therapy (DAPT) for patients at least 12 months post-PCI. It provides a numerical DAPT Risk Score and calculates the percentage risk for key cardiovascular events.



